Autoreactive B cells have critical roles in a large diversity of autoimmune diseases, but the molecular pathways that control these cells remain poorly understood. We performed an in vivo functional screen of a lymphocyte-expressed microRNA library and identified miR-148a as a potent regulator of B cell tolerance. Elevated miR-148a expression impaired B cell tolerance by promoting the survival of immature B cells after engagement of the B cell antigen receptor by suppressing the expression of the autoimmune suppressor Gadd45a, the tumor suppressor PTEN and the pro-apoptotic protein Bim. Furthermore, increased expression of miR-148a, which occurs frequently in patients with lupus and lupus-prone mice, facilitated the development of lethal autoimmune disease in a mouse model of lupus. Our studies demonstrate a function for miR-148a as a regulator of B cell tolerance and autoimmunity.
Immunotolerance ensures that the pool of lymphocytes present in an organism's immune system can react to a vast variety of foreign antigens but do not attack self tissues. Defects in immunotolerance mechanisms constitute the basis for the development of autoimmunity that is characterized by tissue damage caused by self-reactive lymphocytes. Autoreactive B cells have critical roles in a broad spectrum of human autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, diabetes and multiple sclerosis, by producing autoantibodies, presenting autoantigens to T cells and secreting proinflammatory cytokines 1 .
B cell tolerance initiates in the bone marrow at the immature stage of B cell development by a series of mechanisms known as central tolerance. Immature B cells, which express their first functional B cell antigen receptor (BCR), a membrane-bound immunoglobulin M (IgM), arise as the result of successful rearrangement of the genes encoding immunoglobulin heavy and light chains. The combinatorial and stochastic nature of these rearrangements ensures diversity in the BCR repertoire but also generates B cells that recognize self antigens. For removal of these potentially harmful autoreactive B cells, immature B cells undergo the first immunotolerance checkpoint. If the newly generated immature B cell is non-autoreactive, it exits the bone marrow and matures in the periphery. If the immature B cell recognizes self antigens, it continues to rearrange the light chain to generate a non-autoreactive IgM through receptor editing. If receptor editing is unsuccessful, the autoreactive B cell then dies by apoptosis (clonal deletion). Since not all peripheral self antigens are expressed adequately in the bone marrow, additional B cell tolerance checkpoints exist in the periphery 2, 3 . Published studies have shown that autoreactivity is progressively diminished during normal B cell development, which suggests that multiple B cell tolerance mechanisms regulate autoreactive B cells 4, 5 . It has been shown that both central and peripheral B cell tolerance mechanisms are defective in human autoimmune diseases, including lupus, rheumatoid arthritis and multiple sclerosis [6] [7] [8] .
Despite intensive study, the molecular mechanisms underlying B cell tolerance are poorly understood. Specifically, the role of individual microRNAs (miRNAs) in B cell tolerance remains unexplored. miRNAs are endogenously encoded small RNAs 19-23 nucleotides in length that regulate the expression of their target genes by pairing through imperfect sequence complementarity with their target messenger RNAs (mRNAs) and promoting degradation and/or translational repression of the mRNA 9 . Hundreds of miRNAs are expressed in the immune system, and they have essential roles in regulating the development and function of lymphocytes [10] [11] [12] [13] . Expression-profiling studies have revealed that many miRNAs are dysregulated in lymphocytes from patients with autoimmune diseases [14] [15] [16] [17] , and mouse genetic studies have established causative roles for a few of those miRNAs in regulating autoimmunity through T cells [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . However, to our knowledge, no study has addressed the potential contribution of individual miRNAs to the regulation of autoreactive B cells.
We performed a functional screen using a retroviral miRNAexpression library and the 'IgM b -macroself ' mouse model of B cell tolerance 29, 30 . In this model, mice ubiquitously express an engineered membrane-bound superantigen reactive to the constant region of IgM. These mice undergo normal early B cell development, which results in an unaltered immature B cell repertoire. Once B cells reach the immature B cell stage, their membrane-bound IgM recognizes the superantigen, which mimics the recognition of self antigen. In this context, receptor editing is ineffective in eliminating reactivity to the A r t i c l e s superantigen and all developing B cells die by clonal deletion, which results in a nearly complete absence of mature B cells in the spleen and lymph nodes 30 . We took an approach of retroviral transduction and bone marrow reconstitution, in which bone marrow hematopoietic stem and precursor cells (HSPCs) from compatible mice were transduced with retroviruses encoding a miRNA-expression library and were used for the reconstitution of irradiated IgM b -macroself recipient mice. This system provides a clean 'readout' for the identification of miRNAs that control B cell tolerance: if B cells are present in the spleen of those mice after reconstitution, escape from B cell tolerance has occurred and the miRNAs overexpressed by these splenic B cells can then be identified 29 . In the present study, we identified miR-148a as a regulator of B cell tolerance and autoimmunity.
RESULTS

Regulation of B cell tolerance by miR-148a
To identify miRNAs that regulate B cell tolerance, we performed an in vivo functional screen of a retroviral library of 113 lymphocyteexpressed miRNAs, which we divided into four pools (1) (2) (3) (4) , each containing 20-37 miRNAs ( Table 1) . The relatively small pool size was determined on the basis of published studies showing that only 30-50 unique HSPC clones can be successfully engrafted in bone marrow-reconstitution experiments 29, 31 . We used the viral mixtures to transduce HSPCs obtained from the bone marrow of donor C57BL/6J mice that had been inoculated with 5-fluorouracil 4 d before. We then transferred the transduced cells into irradiated recipient IgM bmacroself mice to reconstitute their immune system. At 8 weeks after reconstitution, we euthanized the host mice and analyzed B cells (CD19 + IgM + ) in the spleen. The IgM b -macroself mice that received HSPCs transduced with the control virus, which does not encode any miRNA, had almost no B cells in the spleen (Fig. 1a) . Recipient mice that received cells transduced with retroviruses from pool 2 showed substantial escape from B cell tolerance, as indicated by the presence of a distinct CD19 + IgM + B cell population in the spleen (Fig. 1) . Other retrovirus pools showed marginal effects, if any ( Fig. 1) . Therefore, we focused on pool 2 for the identification of miRNAs that were able to break B cell tolerance.
We used unique sequences (called 'barcodes' here) present in the regions flanking the miRNA hairpin of each miRNA construct of our library (Supplementary Fig. 1a -c) to identify miRNAs that led to the loss of B cell tolerance 29 . B lymphocytes (CD19 + cells) from the spleens of IgM b -macroself mice transduced with retroviruses from pool 2 were purified, and their genomic DNA was extracted and submitted to barcode analysis. Since we started from a pool of retroviruses whose individual members might have different capacities for infecting or affecting the survival and proliferation of HSPCs, we also purified CD19 + IgM − B cell precursors from the bone marrow of the same mice and used their genomic DNA as internal controls. Splenic B cells should show enrichment for retroviral inserts encoding miRNAs that drive the break in B cell tolerance compared with the abundance of such inserts in bone marrow B cell precursors from the same mouse, because the precursor cells have not yet been subjected to selection imposed by the IgM b -macroself superantigen, while splenic B cells represent post-selection cells. Barcode analysis revealed seven miRNAs, miR-511, miR-148a, miR-26a, miR-26b, miR-342, miR-423 and miR-182, for which splenic B cells exhibited an enrichment of more than fourfold relative to their expression in precursor cells ( Fig. 2a,b) .
To confirm that the positive hits were not false-positive results, we used retrovirus encoding each candidate miRNA to transduce donor bone marrow cells from C57BL/6J mice, following the same experimental approach used for the pooled screening experiments.
Among the seven candidate miRNAs, miR-148a had the greatest effect on the break in B cell tolerance, with an average of approximately 16% of B cells among total splenocytes ( Fig. 2c-e ). miR-26a, miR-26b, miR-342, miR-423 and miR-182 led to a more limited loss of tolerance, with corresponding average splenic B cell frequencies ranging from 5% to 8% ( Fig. 2c-e ). Retroviral expression of miR-511 did not rescue B cells from deletion in IgM b -macroself mice, with splenic B cell frequencies close to those of mice reconstituted with control virus-transduced cells, which had approximately 2% B cells among total splenocytes ( Fig. 2c-e ). We also reconstituted IgM b -macroself mice with HSPCs co-infected with a mixture of retroviruses encoding six miRNAs identified in our screen (miR-148a, miR-26a, miR-26b, miR-342, miR-423 and miR-511). Analysis of these mice failed to reveal synergistic effects between these miRNAs in the regulation of B cell tolerance (Supplementary Fig. 2a-c) . These results indicated that the IgM b -macroself model was a robust in vivo system for the identification of miRNAs that regulate B cell central tolerance and demonstrated that miR-148a was a potent regulator of this process.
miR-148a in the protection of immature B cells from apoptosis
Published miRNA-profiling studies have shown that miR-148a expression is tightly regulated throughout B cell development 10 . Pro-and pre-B cells have high expression of miR-148a, which is substantially downregulated after their differentiation into immature and mature B cells and is induced after the activation and differentiation of B cells into germinal center B cells 10 (Supplementary Fig. 3a ). 
A r t i c l e s
Notably, engagement of the BCR increased miR-148a expression only modestly in B cells compared with its expression after stimulation with lipopolysaccharide (LPS), and it diminished LPS-induced miR-148a expression when the two stimuli were used together ( Supplementary  Fig. 3b ). Upregulation of miR-148a expression occurs frequently in autoimmune diseases. Increased expression of miR-148a has been found in B cells, T cells and tissue lesions of human patients with systemic lupus erythematosus, rheumatoid arthritis or multiple sclerosis [14] [15] [16] [17] 32 , as well as in splenic lymphocytes of NZB/W mice at the age of 3-4 months, when overt disease has not yet become evident in this mouse model of lupus 18, 33 . We hypothesized that under physiological conditions, low expression of miR-148a in immature B cells would render autoreactive cells sensitive to apoptosis induced by engagement of the BCR during central B cell tolerance. In humans and mice predisposed to autoimmune diseases, elevated miR-148a expression makes immature B cells resistant to BCRinduced apoptosis, and this leads to the escape of autoreactive B cells from clonal deletion. These autoreactive B cells would then contribute to the development of autoimmune diseases in those individuals.
We tested that hypothesis in the WEHI-231 mouse immature B cell line, an in vitro model of B cell clonal deletion. These cells arrest at the G1 phase of the cell cycle after culture with crosslinking IgM-specific antibodies and subsequently die by apoptosis 34, 35 . Thus, stimulation of WEHI-231 cells with antibody to IgM (anti-IgM) is a widely used method for mimicking the recognition of a self antigen by immature B cells, as it would occur during the central tolerance checkpoint. Similar to mouse immature B cells, these cells had low endogenous expression of miR-148a ( Fig. 3a and Supplementary  Fig. 3a) . To investigate the effect of elevated miR-148a expression on WEHI-231 cells, we transduced these cells with control or miR-148a-expressing retrovirus that also encodes green fluorescent proteins and sorted to purify the transduced cells and generate the stable cell lines WEHI-control and WEHI-miR-148a, respectively. WEHI-miR-148a cells showed more robust miR-148a expression than that of WEHI-control cells (Fig. 3a) . We stimulated these cell lines with anti-IgM and assessed their growth and survival. Consistent with published reports 34, 35 , stimulation of WEHI-control cells with A r t i c l e s anti-IgM led to substantial slowing of their growth (Fig. 3b) . In contrast, WEHI-miR-148a cells exhibited only a transient retardation in growth in response to stimulation with anti-IgM, and they recovered by 72 h (Fig. 3b) . Analysis of apoptosis by staining with annexin V and staining for active caspase 3 showed that a substantial fraction of WEHI-control cells underwent apoptosis in response to stimulation with anti-IgM, while WEHI-miR-148a cells were largely resistant to anti-IgM-induced apoptosis ( Fig. 3c-f ). We assessed the proliferation of WEHI-control and WEHI-miR-148a cells by labeling them with the fluorescent dye CellTrace Violet. After gating on live cells, the dilution of CellTrace Violet over time was similar in WEHI-control cells and WEHI-miR-148a cells (Fig. 3g) , which suggested that miR-148a did not affect proliferation. Therefore, miR-148a controlled B cell central tolerance by regulating the apoptosis of immature B cells after engagement of the BCR.
Targeting of Gadd45a, Bim and PTEN by miR-148a
To gain insight into the molecular mechanisms through which miR-148a regulated BCR engagement-induced apoptosis in immature B cells, we performed RNA-sequencing analysis of WEHI-control and WEHI-miR-148a cells in the presence of stimulation with anti-IgM.
Since elevated miRNA expression promotes the degradation of its target mRNA, the abundance of mRNA targeted by miR-148a should have been lower in WEHI-miR-148a cells than in WEHI-control cells. We identified 119 protein-coding genes that showed a reduction of at least 1.5-fold in expression of their mRNA in WEHI-miR-148a cells and contained predicted miR-148a-binding sites in their mRNA ( Supplementary Table 1 ). Among those, targets encoding products involved in cell survival were of special interest, because our results suggested a role for miR-148a in protecting immature B cells from BCR-induced apoptosis. Thus, we selected for further study four target genes, Bcl2l11 (which encodes the pro-apoptotic factor Bim), Tnfrsf1b (which encodes TNFR2, a receptor for tumor-necrosis factor (TNF)), Pten (which encodes the tumor suppressor PTEN) and Gadd45a (which encodes the autoimmune suppressor Gadd45α), which underwent a miR-148a-mediated reduction in expression of 2.4-fold, 2.3-fold, 1.8-fold and 1.5-fold, respectively. We confirmed the RNA-sequencing results by quantitative RT-PCR and assessed expression of the proteins encoded by these genes by immunoblot analysis (Bim and PTEN) or flow cytometry (TNFR2). The expression of mouse Gadd45α was not measured due to the lack of a suitable antibody. Bcl2l11, Pten and Gadd45a mRNA exhibited a miR-148a-mediated reduction in their expression (Fig. 4a) . The abundance of Bim and PTEN, as well as cell-surface expression of TNFR2, was also reduced by elevated expression of miR-148a ( Fig. 4b and Supplementary Fig. 4a ). We also measured the expression of Gadd45a, Bcl2l11 and Pten mRNA and Bim, TNFR2 and PTEN protein in two other WEHI-231 cell lines with stable expression of other miRNAs (miR-26a and miR-182). miR-26a decreased the expression of Bim and PTEN but not that of Gadd45α or TNFR2, while miR-182 did not affect the expression of any of the targets analyzed ( Supplementary Figs. 4a and 5a,b) .
To demonstrate direct regulation of Bcl2l11, Pten and Gadd45a by miR-148a, we performed dual-luciferase reporter assays. The gene fragment encoding the 3′ untranslated region (UTR) of each target was cloned into an expression vector that encodes renilla luciferase controlled by the cloned 3′ UTR (Supplementary Table 2) . These constructs were transfected into HEK293 human embryonic kidney cells together with an expression vector encoding miR-148a, and the regulation of protein expression by miR-148a was measured. miR-148a significantly reduced reporter protein expression through the 3′ UTRs of Bcl2l11, Pten and Gadd45a (Fig. 4c) . When the binding sites for miR-148a were mutated, this reduction was abolished (Fig. 4c) . Therefore, miR-148a was able to suppress the expression of Bim, PTEN and Gadd45α protein through its cognate binding sites in 3′ UTRs of their respective transcripts. npg
Regulation of B cell central tolerance by Gadd45a, Bim and PTEN
We next investigated whether downregulation of the miR-148a target genes noted above resulted in a break in B cell tolerance. We obtained mice with germline deficiency in Gadd45a, Bcl2l11 or Tnfrsf1b and also generated mice with one or two loxP-flanked Pten alleles (Pten fl ) deleted by Cre recombinase expressed from Cd19 (Cd19-Cre), which drives such deletion specifically in the B cell compartment (Pten fl/+ Cd19-Cre mice and Pten fl/fl Cd19-Cre mice, respectively) [36] [37] [38] [39] [40] . We used bone marrow cells from these mice to reconstitute lethally irradiated IgM b -macroself mice, which we analyzed 8 weeks later. The presence of splenic B cells in recipient mice would indicate that downregulation or complete loss of expression of the corresponding target gene was sufficient to impair B cell central tolerance and that this target gene encoded an important regulator of this process.
When we used Gadd45a −/− mice as bone marrow donors for the reconstitution of lethally irradiated IgM b -macroself mice, we observed a very robust break in B cell tolerance ( Fig. 5a-c) . The frequency and total number of B cells in the spleen were higher than those resulting from retroviral miR-148a expression. It is thought that miRNAs exert their functions by downregulating the expression of their target genes, not by complete shutoff of the target gene expression. For that reason we performed the same bone marrow-reconstitution experiment using Gadd45a +/− mice as bone marrow donors. In this case, a reduction in Gadd45a expression was sufficient for a substantial number of B cells to escape the central tolerance checkpoint. These results revealed a previously unknown role for Gadd45α in regulating B cell central tolerance.
Published studies have shown that Bim and PTEN regulate B cell central tolerance 41, 42 . Complete loss of Bim leads to the accumulation of hen egg lysozyme (HEL)-binding B cells in the spleen of double-transgenic mice with B cell-specific expression of an anti-HEL BCR and ubiquitous expression of a membrane-bound form of HEL protein 41 . Similarly, complete loss of PTEN improves the viability of immature B cells upon crosslinking of the BCR by anti-IgM in cell culture experiments 42 . We reconstituted lethally irradiated IgM b -macroself mice with bone marrow cells from Bcl2l11 +/− , Bcl2l11 −/− , Pten fl/+ Cd19-Cre or Pten fl/fl Cd19-Cre mice. Heterozygous deletion of Bcl2l11 restored B cell development in IgM b -macroself mice to a degree similar to that resulting from retroviral miR-148a expression, and complete loss of Bcl2l11 led to the accumulation of B cells to a frequency and number almost identical to that found in wild-type C57BL/6J mice, which was typically around 55% ± 1.4% B cells and 47 × 10 6 ± 4.4 × 10 6 B cells (mean ± s.e.m.; Fig. 5d-f) . While heterozygous deletion of Pten led to the escape of tolerance by only a relatively small number of B cells, homozygous deletion of Pten resulted in the accumulation of more B cells in the spleen than the amount in wild-type C57BL/6J mice ( Fig. 5g-i) . We also investigated the effect of reduced expression of Tnfrsf1b. Complete deletion of Tnfrsf1b resulted in the accumulation of only a small number of B cells in the spleen of IgM b -macroself mice (Supplementary Fig. 4b-d) . These results demonstrated that Gadd45α, Bim and PTEN were dose-sensitive regulators of B cell central tolerance.
Acceleration of autoimmune-disease development by miR-148a
Published studies have shown that miR-148a is upregulated in lymphocytes from patients with lupus and mouse models of lupus [14] [15] [16] [17] [18] 32, 33 . In the latter, upregulation of miR-148a has been found before disease onset 18, 33 . Those findings suggest that upregulation of miR-148a contributes to the development of lupus, rather than being a consequence of the disease. We next investigated the functional relevance of the upregulation of miR-148a in the development of autoimmune disease in MRL-lpr mice, a model commonly used for lupus research 43 . Consistent with a published report 15 , B cells from 6-week-old MRL-lpr mice were not activated in the periphery but showed a threefold increase in miR-148a expression compared with that of B cells from C57BL/6J control mice ( Supplementary  Fig. 6a,b) . We transduced HSPCs from MRL-lpr mice with control or miR-148a-expressing retrovirus and used these cells to reconstitute lethally irradiated MRL-lpr mice, which we monitored for the development of autoimmune disease. MLR-lpr mice reconstituted with miR-148a-expressing HSPCs showed disease symptoms much earlier than did MLR-lpr mice reconstituted with control vector-transduced HSPCs (Fig. 6a) . Once the mice were sick, the disease also progressed Gadd45a mRNA in WEHI-control and WEHI-miR-148a cells stimulated for 14 h with anti-IgM (2 µg/ml); results are presented relative to those of the control gene Actb. (b) Immunoblot analysis of Bim (isoforms EL, L and S) and PTEN, as well as β-actin (loading control), in cells as in a (left), and ratio of Bim (middle) or PTEN (right) to β-actin, with the ratio in WEHI-control cells set as 1. (c) Dual luciferase reporter assay of HEK293 cells transfected with vector encoding renilla luciferase controlled by the 3′ UTR of wild-type Bcl2l11, Pten or Gadd45a or those genes with mutated cognate binding sites for miR-148a (Bcl2l11-mut, Pten-mut or Gadd45a-mut, respectively), together with vector encoding no miRNA (Control) or miR-148a; results were normalized to those of firefly luciferase and are presented relative to those of cells transfected with vector encoding no miRNA, set as 1. *P < 0.05 and **P < 0.01 (two-tailed Student's t-test). Data are pooled from (a,b) or representative of (c) two independent experiments (mean + s.d. in a,b; mean + s.d. of technical triplicates in c).
A r t i c l e s faster in the group reconstituted with miR-148a-expressing HSPCs, which eventually led to a shorter lifespan for all mice in this group (Fig. 6a) . We measured miR-148a expression in splenic B cells from these mice. The group reconstituted with miR-148a-expressing HSPCs had 5-to 9-fold higher expression of miR-148a than that of the control group reconstituted with control vector-transduced HSPCs (Supplementary Fig. 6c) , which was comparable to the increased expression found in lymphocytes from patients with lupus [14] [15] [16] [17] . We collected serum samples from the mice at various time points and assessed autoantibodies to double-stranded-DNA (dsDNA), a hallmark of lupus pathogenesis 43 . At 8 weeks after reconstitution, low titers of dsDNA autoantibodies were detected in both groups, at similar concentrations (Fig. 6b) . From week 14 and beyond, mice in both groups showed an increase in the concentration of anti-dsDNA autoantibodies, but, on average, the group reconstituted with miR-148a-expressing HSPCs had more anti-dsDNA autoantibodies than did the group reconstituted with control vector-transduced HSPCs, although the differences did not reach statistical significance due to individual variations (Fig. 6b) . We collected secondary lymphoid organs at terminal analysis, then weighed npg them and quantified cells in these organs. The peripheral lymph nodes of mice in the group reconstituted with miR-148a-expressing HSPCs were much bigger than and contained significantly more cells than those in the group reconstituted with control vectortransduced HSPCs, despite the shorter lifespan of the former mice ( Fig. 6c,d) . We found no significant difference in weight or cellularity for the spleen or mesenteric lymph nodes (Fig. 6c,d) . Flow cytometry revealed substantial population expansion of B cells in both the spleen and peripheral lymph nodes of the mice reconstituted with miR-148a-expressing HSPCs (Fig. 6e,f) . These results demonstrated the functional importance of the upregulation of miR-148a expression in autoimmune disease.
DISCUSSION
Expression-profiling studies have shown that dysregulation of miRNA occurs frequently in lymphocytes from human patients with autoimmune diseases 44 . In the present study, we performed an in vivo functional screen of a miRNA library in the IgM b -macroself model and identified miR-148a as a critical regulator of B cell central tolerance and autoimmunity. miR-148a protected immature B cells from apoptosis induced by engagement of the BCR by suppressing the expression of Gadd45a, Bcl2l11 and Pten. Moreover, increased miR-148a expression accelerated the development of lethal autoimmune disease in MRL-lpr mice. Our studies have established miR-148a as a regulator of B cell tolerance and showed that, when dysregulated, miR-148a acted as a driver of autoimmune disease. A miRNA often interacts with mRNAs of hundreds of target genes 9 . However, it has been thought that only a small number of key target genes mediate the function of each miRNA. The functions of these key targets are often sensitive to the cellular concentrations of their proteins 13 . By performing RNA-sequencing analysis of WEHI-231 cells (immature B cells) overexpressing miR-148a, we identified 119 protein-coding genes whose expression was downregulated by miR-148a and that contained miR-148a-binding sites in their mRNA. Because elevated miR-148a expression protected WEHI-231 cells from apoptosis induced by engagement of the BCR, we focused on target genes encoding products involved in the regulation of cell survival. Further analysis identified Gadd45a, Bcl2l11 and Pten as functional targets of miR-148a, as their expression was suppressed by miR-148a and their heterozygous deletion mimicked miR-148a-mediated break of B cell tolerance in the IgM b -macroself model. Bim and PTEN have been shown to have important roles in regulating B cell tolerance and preventing autoimmunity. Both Bcl2l11 +/− mice and Pten +/− mice developed lethal autoimmunity 36, 45 . Complete loss of Bim expression renders immature B cells resistant to BCR-induced apoptosis, breaks B cell central tolerance and impairs B cell anergy in the periphery 41, 46 . Similarly, ablation of Pten protects immature B cells from BCR-induced cell death and impairs B cell anergy 42, 47 . Such findings are consistent with the protective role of miR-148a in WEHI-231 cells. Both WEHI-231 cells and mouse immature B cells have low expression of miR-148a, which might be essential for maintaining their sensitivity to apoptosis induced by engagement of the BCR.
Our study has identified a previously unknown role for Gadd45α in regulating B cell tolerance. Gadd45α is a ubiquitously expressed protein that is often induced by DNA damage and other stress signals associated with growth arrest and apoptosis 48 . Gadd45αdeficient mice develop a lupus-like autoimmune disease characterized by high titers of autoantibodies, lymphoproliferation, autoimmune glomerulonephritis and premature death 40 . Gadd45α has been found to prevent autoimmunity by functioning as a natural inhibitor of spontaneous activation of the kinase p38 in T cells 49 . In this study, we found that Gadd45α also functioned as dose-sensitive regulator of B cell tolerance. Both heterozygous deletion of Gadd45a and its homozygous deletion allowed the escape of autoreactive B cells from the central tolerance checkpoint, which probably contributed to the lethal autoimmune disease that developed in Gadd45a −/− mice.
Notably, a link has been established between Gadd45α expression and Bim function. The Bim isoforms Bim L and Bim EL are normally found associated with motor complexes bound to dynein and sequestered in the cytoskeleton. Bim-induced apoptosis involves the release of Bim L and Bim EL from these microtubule-associated complexes and their translocation to mitochondria. A published study has reported that inducible expression of Gadd45α causes dissociation of Bim from microtubule-associated components and its translocation to mitochondria, where it accumulates and triggers the apoptotic pathway 50 . This suggests functional cooperation between the products of the miR-148a targets Bcl2l11 and Gadd45a in regulation of the apoptosis machinery required for the deletion of autoreactive immature cells during B cell central tolerance.
All three miR-148a target genes (Gadd45a, Bcl2l11 and Pten) that we identified in this study as encoding critical mediators of B cell central tolerance have been linked before to autoimmunity, as mice with homozygous deletion of Gadd45a and mice with heterozygous deletion of Pten or Bcl2l11 developed systemic autoimmune diseases that resemble human lupus. Upregulation of miR-148a occurs frequently in both B cells and T cells of patients with systemic lupus erythematosus or rheumatoid arthritis, as well as in splenic lymphocytes of lupus-prone NZB/W mice even before disease onset [14] [15] [16] [17] [18] 32, 33 , but whether this upregulation has any functional relevance in these diseases has remained unknown. We investigated this in MRL-lpr mice and showed that increased expression of miR-148a significantly accelerated the development of lethal autoimmune disease in these mice, and thus we have established a causative relationship between upregulation of miR-148a and autoimmune disease.
In summary, our study has demonstrated that IgM b -macroself is a robust model for in vivo functional screens for the identification of regulators of B cell central tolerance and that the identification and validation of miRNA target genes is an effective way of identifying genes encoding proteins that regulate immunotolerance. We identified miR-148a as a critical regulator of B cell tolerance and autoimmunity and demonstrated a previously unknown role for Gadd45α in regulating B cell central tolerance. These insights into the mechanisms that control self-tolerance might lead to new strategies for the treatment of autoimmunity.
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